Contract firms identified as helping Johnson & Johnson with what House Oversight committee chair Edolphus Towns (D-NY) has referred to as a “phantom recall” received letters from the committee asking them to detail their roles in the action.
Information requested includes the names of all J&J and McNeil employees who engaged the firms, details on the services provided including all related documentation, and whether the firms have contracted in the past to do similar work for J&J or are currently engaged in similar activities.
The letters, dated June 3, follow a similar letter sent to J&J’s CEO William Weldon on May 28 (IPQ June 3 “In the News”). The letters result from a Congressional hearing on May 27 that brought J&J and FDA to the table to take a hard look at the company’s recent recall and GMP compliance problems (IPQ June 2 “In the News”).
According to information obtained by the committee, WIS of San Diego, California was recruited by Carolina Supply Chain Services (CSCS, now a division of Inmar) “on behalf of Johnson & Johnson” to purchase the affected Motrin. Both firms received letters.
More on this story is provided for subscribers on page 2. Links to related documents are also provided.
Subscribers log in to read more on page 2.
[Editor’s note: The June issue of IPQ will provide an in-depth report on the changing inspection and GMP enforcement landscape in the US, EU, and globally.]
